Active, not recruitingNCT01357668

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bristol-Myers Squibb
Principal Investigator: Bristol-Myers Squibb
Bristol-Myers Squibb
Enrollment: 800 target
Eligibility: 17 years · All sexes
Timeline: 2013 – 2029

Study locations (30)

Local Institution - 0060, Little Rock, Arkansas, United States
Local Institution - 0001, Princeton, New Jersey, United States
Local Institution - 0059, Cincinnati, Ohio, United States
Local Institution - 0025, Bregenz, Austria
Local Institution - 0002, Innsbruck, Austria
Local Institution - 0032, Vienna, Austria
Local Institution - 0010, Botucatu, São Paulo, Brazil
Local Institution - 0026, Campinas, São Paulo, Brazil
Local Institution - 0028, São Paulo, São Paulo, Brazil
Local Institution - 0027, Rio de Janeiro, Brazil
Local Institution - 0029, Calgary, Alberta, Canada
Local Institution - 0011, Montreal, Quebec, Canada
Local Institution - 0035, Aarhus, Central Jutland, Denmark
Local Institution - 0012, Copenhagen, Denmark
Local Institution - 0040, Clermont-Ferrand, Puy-de-Dôme, France
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01357668 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis →

← Back to all trials